OverviewChartNewsTraderScreen

BNP Paribas Bonus Zert SNW 29.12..../  DE000PG1E4B4  /

EUWAX
9/9/2024  9:09:59 AM Chg.- Bid8:08:54 AM Ask8:08:54 AM Underlying Strike price Expiration date Option type
84.61EUR - 84.80
Bid Size: 500		 85.90
Ask Size: 500		 SANOFI SA INHABER ... - EUR 12/29/2025 Call
GlobeNewswire 9/2 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 8/26 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 8/14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 8/13 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/12 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 8/12 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 8/8 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 8/6 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 8/5 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 8/2 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 8/1 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 8/1 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 7/31 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 7/25 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 7/25 Europe lower premarket as earnings pour in
TeleTrader 7/25 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 7/25 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 7/24 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...
GlobeNewswire 7/18 Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, Accord...
GlobeNewswire 7/17 Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transfor...
GlobeNewswire 7/12 FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows ...
GlobeNewswire 7/11 Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Upd...
GlobeNewswire 7/8 Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review ...
GlobeNewswire 7/3 Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients...
GlobeNewswire 7/3 Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD